Last edition
News about "Generic Semaglutide Injection"
Dr Reddy's Receives ANVISA Approval for Generic Semaglutide in Brazil
Dr Reddy’s Laboratories receives ANVISA marketing authorisation for its generic semaglutide injection for adults with inadequately controlled type 2 diabetes in Brazil.
Generic Semaglutide Injection | 05/11/2026 | By News Bureau
OneSource and Orbicular Receive US FDA Tentative Approval for Generic Semaglutide
OneSource and Orbicular secure US FDA tentative approval for generic semaglutide injection, advancing ANDA filing for Ozempic with manufacturing support from OneSource.
Generic Semaglutide Injection | 22/04/2026 | By News Bureau | 331
Sun Pharma Wins DCGI Nod for Generic Semaglutide Injection
Sun Pharmaceutical has secured approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic semaglutide injection for chronic weight management, paving the way for its entry into the fast-growing obesity treatment segment once the semaglutide patent expires in the country.
Generic Semaglutide Injection | 27/01/2026 | By News Bureau | 369
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy